Target Name: Plexin
NCBI ID: P44565
Review Report on Plexin Target / Biomarker Content of Review Report on Plexin Target / Biomarker
Plexin
Other Name(s): PLXN | Plexin | Semaphorin receptor SEX

Understanding The Role of Plexins in Cellular Processes

Plexin (nonspecified subtype) (PLXN), also known as Plexin A3, is a protein that is expressed in many tissues throughout the body. It is a key regulator of the cytoskeleton, which is the structure that gives cells their shape and helps them move and function. Plexin plays a crucial role in the development and maintenance of the cytoskeleton, and is therefore of interest as a potential drug target or biomarker.

Plexins are a family of proteins that belong to the superfamily of coiled-coil transmembrane proteins. They are characterized by a long, N-terminal coiled-coil that can interact with various signaling molecules, as well as a transmembrane region that contains a variety of different domains, including a tyrosine kinase domain, a G protein-coupled receptor (GPCR) domain, and a nucleotide-binding oligomerization domain (NBD domain).

Plexins are involved in many different cellular processes in the cell, including the regulation of cell division, the cytoskeleton, and the cell signaling pathway. They are also involved in the regulation of various signaling pathways, including the TGF-β pathway, which is a well-known regulator of cell growth and differentiation.

One of the key functions of Plexins is their role in regulating the cytoskeleton. The cytoskeleton is the structure that gives cells their shape and helps them move and function. It is made up of a network of filaments and cytoskeleton proteins that are organized in a specific order to create a framework for the cell's cytoplasm. Plexins play a crucial role in the regulation of these cytoskeleton proteins, as well as the overall structure of the cytoskeleton.

Plexins are also involved in the regulation of cell signaling pathways. They can interact with various signaling molecules, including GPCRs, which are proteins that are involved in cell signaling. These interactions can modulate the activity of these signaling molecules, and are therefore important for the regulation of cellular processes such as cell growth, differentiation, and survival.

Plexins have also been shown to be involved in the regulation of cell division. They are often expressed in dividing cells, and have been shown to play a role in the regulation of cell cycle progression. In addition, Plexins have also been shown to be involved in the regulation of cell death, by helping to coordinate the release of cellular signaling molecules that can contribute to cell death.

Plexins have also been shown to be involved in the regulation of the TGF-β pathway. The TGF-β pathway is a well-known regulator of cell growth and differentiation, and is involved in the regulation of many cellular processes, including cell signaling, cell migration, and cell survival. Plexins have been shown to play a role in the regulation of this pathway, by interacting with the TGF-β receptor, which is a protein that is involved in the regulation of TGF-β signaling.

In conclusion, Plexin (nonspecified subtype) (PLXN) is a protein that is expressed in many tissues throughout the body. It is a key regulator of the cytoskeleton, and is therefore of interest as a potential drug target or biomarker. Its functions include the regulation of cell division, the cytoskeleton, and the TGF-β pathway. Further research is needed to fully understand the role of Plexins in cellular processes, and to develop effective treatments for the prevention or treatment of various diseases.

Protein Name: Plexin (nonspecified Subtype)

The "Plexin Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Plexin comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PLG | PLGLA | PLGLB1 | PLGLB2 | PLGRKT | PLIN1 | PLIN2 | PLIN3 | PLIN4 | PLIN5 | PLK1 | PLK2 | PLK3 | PLK4 | PLK5 | PLLP | PLN | PLOD1 | PLOD2 | PLOD3 | PLP1 | PLP2 | PLPBP | PLPP1 | PLPP2 | PLPP3 | PLPP4 | PLPP5 | PLPP6 | PLPP7 | PLPPR1 | PLPPR2 | PLPPR3 | PLPPR4 | PLPPR5 | PLPPR5-AS1 | PLRG1 | PLS1 | PLS3 | PLSCR1 | PLSCR2 | PLSCR3 | PLSCR4 | PLSCR5 | PLTP | PLUT | PLVAP | PLXDC1 | PLXDC2 | PLXNA1 | PLXNA2 | PLXNA3 | PLXNA4 | PLXNB1 | PLXNB2 | PLXNB3 | PLXNC1 | PLXND1 | PM20D1 | PM20D2 | PMAIP1 | PMCH | PMCHL1 | PMCHL2 | PMEL | PMEPA1 | PMF1 | PMF1-BGLAP | PMFBP1 | PML | PMM1 | PMM2 | PMP2 | PMP22 | PMPCA | PMPCB | PMS1 | PMS2 | PMS2P1 | PMS2P12 | PMS2P13 | PMS2P2 | PMS2P3 | PMS2P4 | PMS2P5 | PMS2P9 | PMVK | PNCK | PNISR | PNISR-AS1 | PNKD | PNKP | PNKY | PNLDC1 | PNLIP | PNLIPRP1 | PNLIPRP2 | PNLIPRP3 | PNMA1 | PNMA2